Document is current
Any future updates will be listed below
-
Authors
Sanz, Ana B.
Sanchez-Niño, Maria Dolores
Ramos, Adrian M.
Ortiz, Alberto https://orcid.org/0000-0002-9805-9523
- License Information
-
More Information
Article History
Accepted: 16 February 2023
First Online: 23 March 2023
Competing interests
: A.O. has received grants from Sanofi and consultancy, speaker fees or travel support from Advicciene, Astellas, AstraZeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk and Vifor Fresenius Medical Care Renal Pharma, and is the Director of the Catedra Mundipharma-UAM for diabetic kidney disease and the Catedra Astrazeneca-UAM for chronic kidney disease and electrolytes. A.O. also has stock in Telara Farma. The other authors declare no competing interests.
